Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

OxSyBio

Explore full profile

Developing 3D printing techniques to produce a range of tissue-like and functional tissues for medical research and clinical applications

London, United KingdomFounded 2014Health Tech & Medtech
Valuation $50–100M Last recorded · 2018
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for OxSyBio and the history behind them.

At a glance

Status
Closed
Founded
2014
Headquarters
London, United Kingdom
Employees
1
Open positions
None listed
Dealroom signal
0.0/100
Industry
Health
Sub-industry
Medical Devices
Sector
Health Tech & Medtech, Biotechnology, Synthetic Biology, Spinout, Hard Tech, Longevity, DT and LS, rio ai health, rio AI medical devices
Technology
3D Technology, Deep Tech
Business model
Manufacturing
Client focus
b2b

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Mar 2018 $13M $53M Parkwalk Advisors · IP Group · Woodford Investment Management —
SEEDEquity / VC Apr 2014 $1.3M $5.3M Undisclosed —
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

OxSyBio website traffic

Latest recorded traffic for OxSyBio is 370 monthly website visits, up 48% over the last three months. OxSyBio's team declined 93.8% over the past year.

Latest monthly visits370 3-month web change+48% 1-year team growth-93.8%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • Woodford Investment Management
  • Parkwalk Advisors
  • IP Group

Other known investors3 additional known investors

  • Oxford University Innovation
  • University of Oxford
  • University of Bristol Enterprise Fund
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇬🇧 United Kingdom · London HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about OxSyBio on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See OxSyBio’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.